NASDAQ:ABOS | Free Cash Flow | Acumen Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$24.13M
2025-12-31-$19.1M
2025-03-31-$34.12M
2024-12-31-$27.22M
2024-03-31-$17.86M
2023-12-31-$8.31M
2023-03-31-$10.18M
2022-12-31-$11.2M
2022-03-31-$8.3M
2021-12-31-$3.64M
2021-03-31-$2.37M
2020-12-31-$2.86M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$115.54M
2024-12-31-$86.22M
2023-12-31-$43.06M
2022-12-31-$35.15M
2021-12-31-$17.96M
2020-12-31-$7.45M